Physician profile
Joseph Frank
NPI 1114144177
$1,591.34
in general payments reported to CMS, 2019-2025
22 companies · $468 in 2025
The $468 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.17 · 2022: $38.04 · 2023: $540 · 2024: $524 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $213.74 | 2023-2025 | Bexsero, Rotarix, Pediarix |
| Corium, LLC | $207.89 | 2023-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $162.82 | 2023-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Tris Pharma INC | $146.32 | 2023-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $142.86 | 2023-2024 | Jornay Pm |
| Pfizer INC. | $116.82 | 2023-2025 | |
| Sanofi Pasteur INC. | $69.41 | 2022-2024 | |
| Collegium Pharmaceutical, INC. | $57.16 | 2025 | Jornay Pm |
| Lnhc, INC | $56.38 | 2025 | Zelsuvmi |
| Cranial Technologies, INC | $50.89 | 2023-2025 | Doc Band |
| Acadia Pharmaceuticals INC | $47.09 | 2023-2025 | Daybue |
| Nestle Healthcare Nutrition INC. | $41.80 | 2023 | |
| Verrica Pharmaceuticals INC. | $41.21 | 2023-2024 | Ycanth |
| Alk-Abello, INC | $40.88 | 2025 | Neffy, Odactra, Grastek |
| Seqirus USA INC | $39.14 | 2023-2024 | Flucelvax Quadrivalent, Flucelvax |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $36.73 | 2023 | Cotempla Xr-Odt |
| Cepheid | $25.70 | 2023 | Genexpert |
| Vertical Pharmaceuticals, LLC | $24.35 | 2024 | Relexxii |
| Ars Pharmaceuticals Operations, INC. | $22.37 | 2025 | Neffy |
| Sobi, INC | $21.17 | 2021 | |
| Supernus Pharmaceuticals, INC. | $13.58 | 2023 | Qelbree |
| Baxter Healthcare | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.